Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon?
Sweiss
Nadera J
NJ
Baughman
Robert P
RP
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000069285:Infliximab; D012507:Sarcoidosis / Q000276:immunology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab